Peak Financial Advisors LLC Invests $2.85 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Peak Financial Advisors LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the first quarter, HoldingsChannel.com reports. The fund purchased 5,762 shares of the healthcare conglomerate’s stock, valued at approximately $2,850,000. UnitedHealth Group makes up about 1.7% of Peak Financial Advisors LLC’s investment portfolio, making the stock its 24th largest position.

A number of other large investors also recently modified their holdings of UNH. Texas Capital Bancshares Inc TX lifted its position in UnitedHealth Group by 1.1% in the 3rd quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock valued at $855,000 after purchasing an additional 19 shares during the last quarter. Tealwood Asset Management Inc. lifted its position in UnitedHealth Group by 0.4% in the 4th quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock valued at $2,626,000 after purchasing an additional 19 shares during the last quarter. Atlas Private Wealth Advisors raised its position in shares of UnitedHealth Group by 1.1% during the 4th quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock worth $923,000 after buying an additional 19 shares in the last quarter. Prentice Wealth Management LLC raised its position in shares of UnitedHealth Group by 0.8% during the 4th quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock worth $1,235,000 after buying an additional 19 shares in the last quarter. Finally, Baker Avenue Asset Management LP raised its position in shares of UnitedHealth Group by 1.7% during the 3rd quarter. Baker Avenue Asset Management LP now owns 1,219 shares of the healthcare conglomerate’s stock worth $615,000 after buying an additional 20 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Up 1.5 %

UnitedHealth Group stock opened at $489.99 on Tuesday. The firm has a market cap of $450.98 billion, a PE ratio of 29.95, a P/E/G ratio of 1.40 and a beta of 0.58. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. The firm’s 50 day moving average price is $497.89 and its two-hundred day moving average price is $503.21. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.26 EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 27.57 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th will be given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.71%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date is Monday, June 17th. UnitedHealth Group’s payout ratio is currently 51.34%.

Analyst Upgrades and Downgrades

A number of research firms have commented on UNH. Robert W. Baird began coverage on shares of UnitedHealth Group in a research report on Thursday, May 30th. They set an “outperform” rating and a $597.00 price target on the stock. Piper Sandler lifted their price objective on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. Baird R W raised shares of UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. Bank of America reaffirmed a “buy” rating and issued a $675.00 price objective on shares of UnitedHealth Group in a research note on Thursday, March 7th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research note on Thursday, May 30th. Three research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.